Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Brittany Jasperse"'
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Abstract Zika virus (ZIKV), a flavivirus transmitted primarily by infected mosquitos, can cause neurological symptoms such as Guillian–Barré syndrome and microcephaly. We developed several vaccinia virus (VACV) vaccine candidates for ZIKV based on
Externí odkaz:
https://doaj.org/article/0579b072da9c435fb3f374dfe50845f0
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss , Pp 731-738 (2020)
Vaccinia virus (VACV) was successfully used as a vaccine in the smallpox eradication campaign. Since then, it has been widely used in the development of vaccine and therapeutic vectors. However, methods of generating and purifying recombinant VACVs (
Externí odkaz:
https://doaj.org/article/20564782805d4bf389b34a810fa140b0
Publikováno v:
PLoS ONE, Vol 15, Iss 4, p e0230711 (2020)
Vaccinia virus (VACV) has been used extensively as the vaccine against smallpox and as a viral vector for the development of recombinant vaccines and cancer therapies. Replication-competent, non-attenuated VACVs induce strong, long-lived humoral and
Externí odkaz:
https://doaj.org/article/f04ed48f80634c8fa03b9ee61520fa2d
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-14 (2021)
Scientific Reports
Scientific Reports
Zika virus (ZIKV), a flavivirus transmitted primarily by infected mosquitos, can cause neurological symptoms such as Guillian–Barré syndrome and microcephaly. We developed several vaccinia virus (VACV) vaccine candidates for ZIKV based on replicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::76deb5ca1674cb2fad898633e839660a
https://doaj.org/article/0579b072da9c435fb3f374dfe50845f0
https://doaj.org/article/0579b072da9c435fb3f374dfe50845f0
Publikováno v:
Molecular Therapy: Methods & Clinical Development, Vol 17, Iss, Pp 731-738 (2020)
Molecular Therapy. Methods & Clinical Development
Molecular Therapy. Methods & Clinical Development
Vaccinia virus (VACV) was successfully used as a vaccine in the smallpox eradication campaign. Since then, it has been widely used in the development of vaccine and therapeutic vectors. However, methods of generating and purifying recombinant VACVs (
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ddfdcdd37eb557e6c27f318d8af99e3
https://doi.org/10.1016/j.omtm.2020.03.026
https://doi.org/10.1016/j.omtm.2020.03.026